Search

The new computational infrastructure supports Roche’s vision of building an AI-accelerated healthcare organization

Clinical mass spectrometry has moved decisively from a specialist technique used by a small number of expert laboratories to a core analytical technology underpinning modern diagnostics and translational research. In this brand new SelectScience guide, explore the latest mass spectrometry systems and innovative workflow solutions for clinical laboratories.

The TC-30 improves throughput and data confidence by addressing a critical TD–GC workflow bottleneck

Enhanced gas chromatography platform expands analytical capabilities, increases throughput, and helps laboratories operate more efficiently

New Eppendorf SpinPro 6 R centrifuge maximizes workflow efficiency with flexible, ‘smart’ design

Twelve emerging life science startups to showcase enabling technologies at the SLAS European Conference and Exhibition in Vienna, May 19-21

By offering shared access to instrumentation and experienced cryo-EM scientists, the center allows companies to evaluate and incorporate the technology into existing workflows without building the infrastructure in-house

Michael Richardson explains how Inotiv is unlocking new insights into disease mechanisms and therapeutic effectiveness using spatial transcriptomics, proteomics, and AI-powered image analytics.

Intuitive system provides robust data management tools to support scientific collaboration and engagement with funding bodies through streamlined adherence to FAIR data principles

analytica conference making head-way for microplastics in environmental samples and foodstuffs

Showcasing at analytica 2026, this next-generation analyzer delivers improved sensitivity with proven marine chemistry methods

In an era where algorithmic hypothesis generation outpaces experimental validation capacity, the Centre of Excellence positions Arctoris at the critical interface between computational design and empirical truth

The certification includes conformity assessment for near-patient testing, enabling its use outside traditional laboratories, directly at the point of care

Three therapeutic targets selected across high‑value clinical indications pipeline planned for four radiotherapy assets with in vivo data expected by end of 2026